Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Funct ; 14(13): 5936-5948, 2023 Jul 03.
Artículo en Inglés | MEDLINE | ID: mdl-37337869

RESUMEN

Chronic over-exposure to UV radiation leads to the damage of skin tissue. The aim of this study was to investigate the effects of collagen peptide (CP) and antioxidant (astaxanthin, vitamin C (Vc), and vitamin E (Ve)) combinations on skin photoaging. Forty male UV-induced BALB/c mice were randomized and fed saline or CP and antioxidants for 7 weeks using gavage feeding. The results showed that oral administration of CP, CP combined with Vc and Ve (VCE) or Haematococcus pluvialis extract (HPE) significantly (P < 0.05) reduced a* of mouse skin and increased the content of Hyp and type I collagen to varying degrees, thereby improving skin integrity. Furthermore, the combination of CP, HPE, and VCE showed increased upregulation of antioxidant enzyme expression, reduced serum ROS, and decreased inhibition of metalloproteinase expression compared to the other treatment groups. Thus, this combination showed better effects in inhibiting collagen degradation and maintaining the redox balance. The Nrf2/ARE and TGF-ß/Smad transcription systems are likely involved in these effects. Therefore, the results suggest that a diet containing CP, astaxanthin, and vitamins might be recommended to improve skin health and appearance.


Asunto(s)
Envejecimiento de la Piel , Tilapia , Masculino , Ratones , Animales , Antioxidantes/metabolismo , Tilapia/metabolismo , Rayos Ultravioleta/efectos adversos , Transducción de Señal , Colágeno/metabolismo , Piel , Factor de Crecimiento Transformador beta/metabolismo
2.
Food Funct ; 14(14): 6385-6396, 2023 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-37325857

RESUMEN

Dietary intervention with the probiotic Lactobacillus rhamnosus CCFM1060 has been proved to be effective on glycemic regulation in diabetic mice. Therefore characterization of the potential symbiotic effect of prebiotic xylooligosaccharides (XOS) with L. rhamnosus CCFM1060 would be desirable. In this study, we evaluated any dose-dependent relationship between XOS and L. rhamnosus CCFM1060, and the potential impact on glycemic regulation. Diabetic mice were randomly assigned to receive 5 × 109 CFU mL-1L. rhamnosus CCFM1060, 5 × 109 CFU mL-1L. rhamnosus CCFM1060 with 250 mg kg-1 XOS (L-LXOS), or 5 × 109 CFU mL-1L. rhamnosus CCFM1060 with 500 mg kg-1 XOS (L-HXOS) for 7 weeks. In addition to characterization of the host metabolism, the intestinal microbiota were analyzed using 16S rRNA gene sequencing. The results showed that L. rhamnosus alone and L-LXOS intervention significantly alleviated diabetes symptoms and increased the populations of short-chain fatty acid (SCFA)-producing bacteria. The intake of L-HXOS had an adverse effect on glucose metabolism, causing increased insulin resistance and inflammation. Although a significant increase in the relative abundance of Bifidobacterium was observed in the L-HXOS group, the abundance of SCFA-producing bacteria, such as Romboutsia and Clostrudium sensu stricto 1, decreased. KEGG pathway analysis revealed that the adverse effects of L-HXOS intervention might be attributed to the metabolic pathways involved in amino acid, cofactor, and vitamin metabolism. This study revealed that L. rhamnosus CCFM1060 combined with different doses of XOS exerted dose-dependent effects on glucose metabolism. Therefore, the type and dose of prebiotics should be carefully evaluated when developing individualized symbiotic formula.


Asunto(s)
Diabetes Mellitus Experimental , Probióticos , Animales , Ratones , ARN Ribosómico 16S/genética , Diabetes Mellitus Experimental/tratamiento farmacológico , Oligosacáridos/metabolismo , Ácidos Grasos Volátiles/metabolismo , Bacterias , Glucosa/metabolismo
3.
Food Funct ; 13(21): 10882-10894, 2022 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-36222359

RESUMEN

The biological effects of ginsenosides are limited by their low oral bioavailability. This study aimed to investigate the effects of particle size reduction and dispersants on the dissolution and bioavailability of ginsenosides in ginseng. Fine ginseng powder (FGP), ultrafine ginseng powder (UGP), and ultrafine ginseng powder with ß-cyclodextrin as the dispersant (UGPD) were prepared using a planetary ball mill from coarse ginseng powder (CGP, as the control). The particle size, morphology, hydration, thermal properties, and in vitro dissolution behavior of ginseng powders were characterized. The relative oral bioavailability of ginsenosides (9 protopanaxadiol (PPD)-type and 7 protopanaxatriol (PPT)-type) was determined in a rat model. Both UGP and UGPD displayed improved physiochemical properties (e.g. reduced particle size, increased hydration and thermal properties). The total in vitro dissolution of ginsenosides from UGPD was ∼17.2% higher than that from CGP; in contrast, UGP did not differ from CGP. More importantly, the in vivo pharmacokinetic study showed that the relative bioavailability of a total of 16 ginsenosides in UGPD was 180.1 ± 9.9% (CGP set as 100%), which was significantly greater than that in FGP and UGP. This suggested that dispersants were essential for preserving the benefits of ultrafine milling by preventing ultra-pulverization induced agglomeration. In particular, PPD-type ginsenosides showed similar deglycosylation trends in in vitro and in vivo experiments; in contrast, the deglycosylation states of PPT-type ginsenosides varied, which might be attributed to the relatively low abundance, glycosylation linkage, and potential involvement of the gut microbiota metabolism. Conclusively, ultrafine milling combined with a dispersant provides a simple and scalable manufacturing process that can effectively improve the bioavailability of ginseng products.


Asunto(s)
Ginsenósidos , Panax , beta-Ciclodextrinas , Ratas , Animales , Panax/química , Ginsenósidos/química , Disponibilidad Biológica , Polvos , Solubilidad , Tamaño de la Partícula
4.
Food Funct ; 12(3): 1008-1019, 2021 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-33502407

RESUMEN

High-protein diets are known to reduce weight and fat deposition. However, there have been only a few studies on the efficacy of different types of high-protein diets in preventing obesity. Therefore, the emphasis of this study lies in comparing the efficacy of two high-protein diets (milk protein and whey protein) in preventing obesity and exploring specific mechanisms. Eighty Sprague Dawley rats were divided into two groups and fed with milk protein concentrate (MPC) and whey protein concentrate (WPC) for 12 weeks. Each group was divided into four levels: two low-fat regimens with either low or high protein content (L-14%, L-40%) and two high-fat regimens with either low or high protein content (H-14%, H-40%). The studies we have performed showed that rats treated with MPC at the 40% protein level had significantly reduced body weight, fat weight and fat ratio gain induced by a high-fat diet, while the protein level in the WPC group had no effect on body weight or body fat in rats fed with a high-fat diet. What is more, rats fed with MPC at the H-40% energy level showed a significant decrease in plasma triglyceride, total cholesterol and low-density lipoprotein cholesterol levels and a significant increase in plasma high-density lipoprotein cholesterol levels compared with the H-14% energy level group. In contrast, in the WPC groups, increasing the protein content in high-fat diets had no significant influence on plasma lipid levels. The results of the amino acid composition of the two proteins and plasma showed that the MPC diet of 40% protein level increased the transsulfuration pathway in rats, thereby increasing the level of H2S. This research work has shown that not all types of high-protein diets can effectively prevent obesity induced by high-fat diets, as effectiveness depends on the amino acid composition of the protein.


Asunto(s)
Adiposidad/efectos de los fármacos , Dieta Rica en Proteínas , Proteínas de la Leche/farmacología , Proteína de Suero de Leche/farmacología , Factor de Transcripción Activador 4 , Tejido Adiposo , Animales , Antioxidantes , Peso Corporal/efectos de los fármacos , Dieta con Restricción de Grasas , Dieta Alta en Grasa , Modelos Animales de Enfermedad , Expresión Génica , Sulfuro de Hidrógeno , Metabolismo de los Lípidos/genética , Masculino , Obesidad/prevención & control , Ratas , Ratas Sprague-Dawley , Triglicéridos
5.
Int J Food Sci Nutr ; 65(8): 981-8, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25156454

RESUMEN

Sesaminol triglucoside is a major lignin in sesame meal and has a methylenedioxyphenyl group and multiple functions in vivo. As a tetrahydrofurofuran type lignan, sesaminol triglucoside is metabolized to mammalian lignans. This investigation studies the effect of sesaminol triglucoside and its tetrahydrofuranoid metabolites (sesaminol, 2-episesaminol, hydroxymethyl sesaminol-tetrahydrofuran, enterolactone, and enterodiol) on gene expression in primary rat hepatocytes using a DNA microarray. Sesame lignans significantly affected the expression of xenobiotic-induced transcripts of cytochrome P450, solute carrier (SLC), and ATP-binding cassette (ABC) transporters. Changes in gene expression were generally greater in response to metabolites with methylenedioxyphenyl moieties (sesaminol triglucoside, sesaminol, and 2-episesaminol) than to the tetrahydrofuranoid metabolites (hydroxymethyl sesaminol-tetrahydrofuran, enterolactone, and enterodiol). Tetrahydrofuran lignans, such as sesaminol triglucoside, sesamin, hydroxymethyl sesaminol-tetrahydrofuran, and sesaminol changed the expression of ABC transporters.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Dioxoles/metabolismo , Furanos/metabolismo , Glucósidos/metabolismo , Lignanos/metabolismo , Hígado/metabolismo , Sesamum/química , 4-Butirolactona/análogos & derivados , 4-Butirolactona/metabolismo , Animales , Sistema Enzimático del Citocromo P-450/metabolismo , Dioxoles/farmacología , Furanos/farmacología , Expresión Génica , Perfilación de la Expresión Génica , Hepatocitos/metabolismo , Inactivación Metabólica/efectos de los fármacos , Inactivación Metabólica/genética , Lignanos/farmacología , Mamíferos , Extractos Vegetales/metabolismo , Extractos Vegetales/farmacología , Ratas Sprague-Dawley , Semillas/química
6.
Int J Mol Sci ; 15(6): 9979-90, 2014 Jun 04.
Artículo en Inglés | MEDLINE | ID: mdl-24901528

RESUMEN

Selective isolation of Kunitz trypsin inhibitor (KTI) and lectin from soybean whey solutions by different types of chitosan beads was investigated. The chitosan beads were co-crosslinked with tripolyphosphate/genipin in solutions at pH 5, 7 or 9 (CB5, CB7, CB9). The maximum adsorption ratios of chitosan beads to KTI and lectin were observed at pH 4.4 and 5.4, respectively; highly selective separation was also demonstrated at these pHs. The adsorption ratios increased with temperature, rising between 5 and 25 °C. CB9 produced the best adsorption ratio, followed by CB7 then CB5. The critical interaction governing absorption of chitosan beads to KTI and lectin could be hydrogen bonding. At pH 9, KTI and lectin desorbed efficiently from CB7 with desorption ratios of 80.9% and 81.4%, respectively. The desorption was most likely caused predominantly by electrostatic repulsion. KTI and lectin can effectively be selectively isolated from soybean whey using this novel separation technique.


Asunto(s)
Quitosano/química , Glycine max/química , Iridoides/química , Lectinas de Plantas/aislamiento & purificación , Proteínas de Plantas/aislamiento & purificación , Polifosfatos/química , Inhibidores de Tripsina/aislamiento & purificación , Adsorción , Reactivos de Enlaces Cruzados/química , Concentración de Iones de Hidrógeno , Soluciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...